Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 10 May 2022 for Surgalign Holdings, INC., €351.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joshua H. DeRienzis: trading record in brief
Joshua H. DeRienzis (senior executive) discloses dealings in 2 companies, chiefly Surgalign Holdings, Inc. and PSS World Medical Inc. Between 18 February 2009 and 7 May 2022, the trades on record add up to 19 filings.
No open-market purchase appears, only 1 sale worth €28k. Outside the open market, there are 16 share grants.
On 10 May 2022 came the latest disclosure, a share grant for €1,475 in Surgalign Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joshua H. DeRienzis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,019 shares@ US$0.18320.6% of flowCommon StockSEC:0001209191-22-028012:0
5,409 shares@ US$0.271879.4% of flowCommon StockSEC:0001209191-22-024002:0
163,637 shares0Common StockSEC:0001209191-21-058583:0
104,697 shares0Common StockSEC:0001209191-21-031234:0
4 of 4 declarations
